The P protein of rabies virus (RABV) is known to interfere with the phosphorylation of the host IFN regulatory factor 3 (IRF-3) and to consequently inhibit type I IFN induction. Previous studies, however, have only tested P proteins from laboratory-adapted fixed virus strains, and to the best of our knowledge there is no report about the effect of P proteins from street RABV strains or other lyssaviruses on the IRF-3-mediated type I IFN induction system. In this study, we evaluated the inhibitory effect of P proteins from several RABV strains, including fixed and street virus strains and other lyssaviruses (Lagos bat, Mokola and Duvenhage viruses), on IRF-3 signalling. All P proteins tested inhibited retinoic acid-inducible gene-1 (RIG-I)-and TANK binding kinase 1 (TBK1)-mediated IRF-3-dependent IFN-b promoter activities. On the other hand, the P proteins from the RABV street strains 1088 and HCM-9, but not from fixed strains Nishigahara (Ni) and CVS-11 and other lyssaviruses tested, significantly inhibited I-kappa B kinase e (IKKe)-inducible IRF-3-dependent IFN-b promoter activity. Importantly, we revealed that the P proteins from the 1088 and HCM-9 strains, but not from the remaining viruses, interacted with IKKe. By using expression plasmids encoding chimeric P proteins from the 1088 strain and Ni strain, we found that the C-terminal region of the P protein is important for the interaction with IKKe. These findings suggest that the P protein of RABV street strains may contribute to efficient evasion of host innate immunity.
INTRODUCTION
Rabies is fatal and is accompanied by severe neurological symptoms with 100% mortality. The aetiological agent, the rabies virus (RABV), infects the central nervous system (CNS) of most mammals, including humans. It belongs to the family Rhabdoviridae (genus Lyssavirus, order Mononegavirales), and the genus Lyssavirus also includes rabies-related lyssaviruses such as Lagos bat virus (LBV), Mokola virus (MOKV) and Duvenhage virus (DUVV) Nolden et al., 2014) . Human RABV infection is estimated to cause more than 55 000 deaths every year, mainly in Asia and Africa . Other lyssavirus species have also been reported to cause lethal diseases in humans . RABVs are generally classified into two groups, namely, street viruses (field isolate strains) and fixed viruses (laboratory-adapted strains) (Dietzschold et al., 2008) . Fixed viruses are established by serial passaging of street viruses in animal brains and/or cell cultures and are less pathogenic than street viruses after peripheral inoculation (Lépine, 1938) .
The genome of lyssaviruses is an unsegmented negative sense RNA of about 12 000 bases, and it contains five genes (N, P, M, G and L genes) encoding nucleoprotein (N protein), phosphoprotein (P protein), matrix (M) protein, glycoprotein (G protein) and large (L) protein, respectively (Schnell et al., 2010) . The N, P and L proteins together with the viral genomic RNA form a ribonucleoprotein (RNP) complex. During viral assembly in virusinfected cells, the RNP complex is enclosed in an envelope containing the M and G proteins. The N protein enwraps viral RNA to form a template for replication and transcription, and the L protein functions as an RNA-dependent RNA-polymerase together with a cofactor, the P protein . The P protein is a multifunctional protein that also associates with the N protein to act as a chaperone to support specific RNA encapsidation (Chenik et al., 1994 (Chenik et al., , 1998 . Recent studies have shown that the P protein of RABV interacts with host factors, such as focal adhesion kinase (Fouquet et al., 2015) and nucleolin (Oksayan et al., 2015) to regulate viral multiplication. Additionally, it acts as an antagonist of host innate immunity and thus is involved in pathogenesis .
A key aspect of the antiviral innate immune response is the synthesis and secretion by infected cells of type I IFNs, such as IFN-a and IFN-b, which induce an antiviral state in cells (Bonjardim, 2005; Randall & Goodbourn, 2008) . The response is triggered when the viral infection is recognized by specific cellular pathogen recognition receptors (PRRs) . Previous studies have shown that RABV infection is recognized by a cytoplasmic PRR, retinoic acid-inducible gene I (RIG-I) (Hornung et al., 2006; Masatani et al., 2010) . Upon activation, RIG-I induces downstream signalling by binding to an adaptor molecule, mitochondrial antiviral signalling (MAVS) protein, which subsequently activates TANK-binding kinase 1 (TBK1) and I-kappa B kinase e (IKKe). Activated TBK1 and IKKe catalyse the phosphorylation and dimerization of IFN regulatory factor 3 (IRF-3) in the cytoplasm. Phosphorylated IRF-3 is translocated to the nucleus and activates the transcription of type I IFNs, IFN-a and -b. Secreted type I IFNs bind to a common receptor and activate Janus kinase/signal transducer and activator of transcription (JAK/STAT) signalling, which subsequently induces transcription of hundreds of IFN-stimulated genes (ISGs) including antiviral and apoptotic genes (Randall & Goodbourn, 2008; van Boxel-Dezaire et al., 2006) . Previous studies reported that the P protein of RABV antagonizes JAK/STAT signalling by interacting with STAT-1, -2 and -3 (Vidy et al., 2005 (Vidy et al., , 2007 Brzó zka et al., 2006; Ito et al., 2010; Lieu et al., 2013; Wiltzer et al., 2014) . In addition, the RABV P protein also interferes with TBK1 and IKKe-mediated IRF-3 activation and consequently inhibits type I IFN induction (Brzó zka et al., 2005; Rieder et al., 2011) . However, the host factor(s) involved in IRF-3 activation that are targeted by P proteins are unknown, and the detailed mechanism underlying P protein-mediated inhibition of IFN induction is unclear.
In this study, we compared the influence of P proteins from several RABV strains, including fixed and street strains and other lyssaviruses, on type I IFN induction signalling. We found that P proteins from all RABV strains and lyssaviruses tested in this study inhibit TBK1-mediated signalling. Moreover, P proteins from RABV street strains, but not from fixed strains, directly interacted with IKKe and inhibited IKKe-mediated IRF-3 activation. This P protein-IKKe interaction may play a role in the evasion of cellular antiviral response and pathogenicity of RABV street strains.
RESULTS
Comparison of the effect of P proteins from various lyssavirus strains on IFN-b promoter activity
We constructed plasmids for the expression of N-terminally Flag-tagged P proteins from various strains, including a RABV fixed strain Nishigahara (Ni) (Ishikawa et al., 1989) , a street strain 1088, which was originally isolated from a woodchuck in the USA and has high pathogenicity after peripheral infection in mice (Mifune et al., 1979) and three lyssaviruses LBV, MOKV and DUVV. Expression levels of all P proteins in the plasmid-transfected cells were comparable (Fig. 1a) . We examined the effect of these P proteins on the IFN-b promoter activity by using the Newcastle disease virus (NDV) vaccine strain as an inducer. We found that NDV-induced IFN-b promoter activity was impaired by all P proteins tested (Fig. 1b) . Importantly, the inhibitory effect of the P protein from the 1088 strain was significantly greater than that of other P proteins tested. It should be noted that the addition of a Flag-tag at the N-terminus of P proteins from Ni and 1088 strains did not affect their IFN-b promoter inhibition activity (Fig. S1 , available in the online Supplementary Material).
A previous study showed that NDV infection is recognized by RIG-I, resulting in the activation of the RIG-I-inducible IFN pathway . Thus, we assessed the ability of P proteins to inhibit RIG-I-mediated IFN-b promoter activity by overexpressing the constitutively active mutant of RIG-I, RIG-IN (Fig. 1c) . In agreement with the aforementioned results (Fig. 1b) , all P proteins inhibited RIG-IN-inducible IFN-b promoter activity and the inhibitory effect of the P protein from the 1088 strain was significantly greater than that of others. These results suggest that the antagonist functions of P proteins with respect to IFN-b promoter activity are conserved across the genus.
Comparison of the ability of P proteins from RABV and other lyssavirus to inhibit IRF-3 activity Next, we examined the ability of the P proteins to inhibit the activation of an IRF-3-dependent IFN-b promoter (Fig. 2a) . We found that all P proteins inhibited RIG-IN-inducible IRF-3-dependent IFN-b promoter activity.
Notably, the promoter activity in cells expressing the P protein from the 1088 strain was significantly lower than that in cells expressing other lyssavirus strain-derived P proteins. On the other hand, IRF-3-dependent IFN-b promoter activity induced by overexpression of the constitutively active IRF-3 mutant (IRF-3-5D) was not inhibited by any of the P proteins (Fig. 2b) , indicating that lyssavirus P proteins inhibit activation of IRF-3 and/or the upstream signalling pathway.
The P protein from the 1088 strain inhibits IKKe-mediated IRF-3 activation Two closely related kinases, TBK1 and IKKe, are involved in the direct phosphorylation of IRF-3 (Shimada et al., 1999; Fitzgerald et al., 2003; Sharma et al., 2003) . Thus, we examined the inhibitory effects of the P proteins on TBK1-or IKKe-mediated IRF-3 activation (Fig. 3) . All P proteins inhibited TBK1-mediated IRF-3-dependent IFN-b promoter activity to the same degree ( Fig. 3a) , indicating that the antagonist functions of the tested P proteins with respect TBK1-mediated IRF-3 activation are conserved across the genus. While P proteins from Ni, LBV, MOKV and DUVV did not inhibit IKKe-mediated IRF-3-dependent IFN-b promoter activity, the P protein from the 1088 strain significantly inhibited the activity (Fig. 3b) . We confirmed the same results by using human neuroblastoma cell line SYM-I (Fig. 3c, d ).
To confirm the strain-specific inhibition of IKKe activity by 1088 P protein, we assessed phosphorylation of IRF-3 in 293T cells co-transfected with the IKKe expression plasmid and P protein expression plasmids (Fig. 4) . Notably, consistent with result of the above reporter assay (Fig. 3b) , the P protein from the 1088 strain, but not from other strains, inhibited IKKe-mediated phosphorylation of IRF-3. Together, these data indicated that the P protein from the 1088 strain has the ability to inhibit IKKe-mediated IRF-3 activation.
The P protein from 1088 strain interacts with IKKe
To examine whether the P protein from the 1088 strain interacts with IKKe directly, we performed a co-immunoprecipitation assay. We generated plasmids expressing myc-tagged IKKe and TBK1 and confirmed that the myctagged kinases activated IRF-3-dependent IFN-b promoter activity. Notably, the promoter activities were affected by P proteins from 1088 and Ni strains as in the case of Flag-tagged kinases (Fig. S2 ). 293T cells were co-transfected with myc-tagged IKKe or TBK1, together with Flag-tagged P proteins from the RABV Ni strain, 1088 strain and lyssavirus MOKV. At 24 h post-transfection, cell lysates were precipitated with anti-Flag or anti-myc antibody-coated magnetic beads and immunocomplexes were analysed by Western blotting (Fig. 5 ). Not all P proteins associated with TBK1: while P proteins from the Ni strain and MOKV did not associate with IKKe, we found that the P protein from the 1088 strain specifically associated with IKKe.
Comparison of the abilities of P proteins from other RABV strains to inhibit IKKe-mediated IRF-3 activity
To investigate whether the P protein from the 1088 strain could inhibit IKKe-mediated IRF-3 activity and if the interaction with IKKe is unique to this strain, we examined the inhibitory effect of P proteins from other RABV strains on IKKe activity. We constructed expression plasmids of N-terminally Flag-tagged P proteins from a RABV fixed strain, CVS-11 strain, and a street HCM-9 strain, which was originally isolated from a rabid dog in Vietnam (Yamagata et al., 2007) . While the P protein from the CVS-11 strain did not inhibit IKKe-mediated IRF-3 activation, the P protein from the HCM-9 strain showed strong inhibitory effects (Fig. 6a) . Moreover, the coimmunoprecipitation and Western blotting assays indicated that the P protein from the HCM-9 strain, but not from the CVS-11 strain, interacted with IKKe ( Fig. 6b) , indicating that the ability to interact with IKKe and the inhibitory activity is conserved among RABV street strains.
The C-terminal region of the 1088 P protein is important for inhibition of IKKe-mediated IRF-3 activity
To identify the functional region in P proteins responsible for the inhibition of IKKe-mediated IRF-3 activity, we constructed a chimeric P protein composed of the N-terminus region (aa 1-151) of the P protein from the Ni strain and a C-terminus region (aa 152-297) of the P protein from the 1088 strain. The counterpart comprised an N-terminus region of the P protein from the 1088 strain and a C-terminus region of the P protein from the Ni strain (Fig. 7a) . We confirmed that the expression levels of these chimeric P proteins and parental proteins were almost the same (Fig. 7b) . Comparison of the inhibitory effects of these chimeric P proteins on IKKe-mediated IRF-3 activity was conducted via a reporter assay (Fig. 7c) . Importantly, while the Ni-10 P protein significantly inhibited IKKemediated IRF-3 activation at the same level as the P protein from the 1088 strain, the 10-Ni P protein did not (Fig. 7c) . The co-immunoprecipitation and Western blotting assays showed that the chimeric Ni-10 P protein, but not the counterpart 10-Ni P, interacted with IKKe, similarly to the P protein from the 1088 strain (Fig. 7d) . These findings indicate that the C-terminal region of the RABV P protein is important for interaction with IKKe and inhibition of its activation. To identify which amino acid residue is responsible for the different phenotype of the strains, we constructed plasmids encoding single point-mutated 1088 P proteins (pCAG-Flag-1088P: L169S, -1088P: T173M or -1088P: M174A) in which single amino acids at position 169, 173 or 174 of P protein (chemically different residues between Ni P and 1088 P) were replaced by those from the Ni P in the backbone of the 1088 P, respectively, and validated the effect of mutation for IKKe-mediated IRF-3-dependent promoter activity (Fig. S3d) . While both 1088 P(L169S) and 1088 P(M174A) proteins inhibited IKKe-mediated IRF-3 activation at the same level as the parental 1088 P protein, the inhibitory activity of 1088 P (T173M) was slightly lower than that of 1088 P. The function of the 1088 P protein for inhibition of IKKe-mediated IRF-3 activity was not completely removed by the single mutations. This result suggests that multiple residues in the P protein are related to the phenotype.
DISCUSSION
The RABV P protein interferes with the phosphorylation of host IRF-3 and activation of JAK/STAT signalling . A recent study showed that the mechanism of inhibition of JAK/STAT signalling is conserved among the P proteins of RABV street viruses, fixed viruses, and other lyssaviruses (LBV, MOKV, Australian bat lyssavirus and European bat lyssavirus-1) (Wiltzer et al., 2012) . However, on IRF-3 activation and IFN induction, previous studies tested only P proteins from a fixed virus (SAD L16 and CVS strains) (Brzó zka et al., 2005; Rieder et al., 2011; Wiltzer et al., 2012) and there is no report about the suppressive effect of P proteins from other RABV strains or other lyssaviruses on the IRF-3-dependent type I IFN induction system. In this study, we compared the inhibitory effects of P proteins from various RABV strains (including fixed viruses and street viruses) and other lyssaviruses on type I IFN induction signalling. We demonstrated that the inhibitory activity of P proteins from RABV strains and other lyssaviruses on TBK1-mediated IRF-3 activity is conserved among strains. Importantly, we showed that P proteins from two RABV street strains tested in this study, but not from fixed strains tested and other lyssaviruses, interacted with IKKe and prevented IKKe-mediated IRF-3 signalling (Fig. 8) .
Both IKKe and TBK1 are IKK-related kinases, which play primary roles in antiviral signalling. These kinases commonly phosphorylate IRF-3 and IRF-7, leading to the nuclear translocation of these transcription factors and subsequent induction of type I IFN promoters (Pham & Tenoever, 2010) . Recent studies revealed that the two kinases have distinct roles in innate immunity: TBK1 plays Fig. 5 . P protein of RABV 1088 strain interacts with IKKe. 293T cells were co-transfected with pCAG-Flag-1088P, pCAG-FlagNiP or pCAG-Flag-MOKVP, and pCAG-myc-TBK1 or pCAG-mycIKKe. An empty vector pCAGGS/MCS was used as a negative control. At 24 h post-transfection, cells were lysed and co-immunoprecipitation (Co-IP) was performed using the anti-Flag and anti-myc monoclonal antibodies. Immunocomplexes were separated by SDS-PAGE and analysed by Western blotting with antibodies to Flag-tag and myc-tag to detect P protein and TBK1 or IKKe, respectively. Whole-cell lysates (WCL) were also analysed by Western blotting and are shown in lower panels. Results are from a single experiment representative of three independent assays.
Rabies virus P targets to IKKe
a dominant role in type I IFN induction in response to viral infection (Pham & Tenoever, 2010) , while IKKe directly phosphorylates STAT1 and regulates the induction of ISGs (Tenoever et al. 2007 ). IKKe-mediated activation of STAT1 affects the quality of the gene transcription profile in both type I and II IFNs (Ng et al., 2011) . Furthermore, IKKe has been found to be important for the direct phosphorylation of specific NFkB subunits and induction of a specific subset of pro-inflammatory cytokines (Adli & Baldwin, 2006; Pham & Tenoever, 2010) . Therefore, in addition to suppressing IRF-3 signalling, P proteins from street RABV strains inhibit IKKe, which may contribute to the suppression of STAT1 and NFkB activation.
Previous studies reported that RABV P protein inhibits TBK1-mediated IRF-3 activation (Brzó zka et al., 2005; Rieder et al., 2011) , which is consistent with our results (Fig. 3a) . However, although all tested P proteins strongly suppressed TBK1-mediated IRF-3 activity, we did not observe direct interactions between TBK1 and P proteins (Fig. 5) . The phosphotransferase activities of TBK1 and IKKe are regulated by scaffolding effector proteins, such as NAK associated protein 1 (NAP1), similar to NAP TBK1 adaptor (SINTBAT), TNF-receptor associated factor 3 (TRAF3), and TRAF family memberassociated NFkB activator (TANK) (Pham & Tenoever, 2010) . Therefore, it is conceivable that P proteins may target these effector protein(s). Further studies would be required to identify the target of P proteins for the suppression of the TBK1-mediated IRF-3 activity.
We demonstrated that while P proteins from RABV street strains 1088 and HCM-9 interacted with IKKe and inhibited its activity, P proteins from RABV fixed strains Ni and CVS-11 did not possess this ability. In general, RABV street strains are more pathogenic than fixed viruses when inoculated via peripheral sites, and it is considered that evasion of innate immunity at peripheral sites (such as skin and muscles) is responsible for their high invasion into neurons from peripheral sites (Dietzschold et al., 2008) . Moreover, a recent study showed that a street RABV strain (DRV strain) is more sensitive to IFN treatment than a laboratory-adapted fixed strain (B2C strain) and it was suggested that while street RABV strains are more sensitive to IFN treatment than laboratory-adapted RABV, they can strongly suppress IFN induction in host cells (Niu et al., 2013) . Thus, the ability of the P protein to inhibit IKKe-mediated signalling may contribute to the strong interference with IFN induction by street viruses. However, it has been shown that P proteins from the low-pathogenic fixed virus, SAD L16 strain, also inhibited IKKe-mediated phosphorylation of IRF-3 (Rieder et al., 2011) , indicating that not all P proteins of fixed strains are unable to target IKKe. This inhibitory effect may be conserved in street RABV strains circulating in nature, while several fixed strains such as Ni and CVS-11 have lost the function in the course of passaging, but several strains such as SAD L 16 retain this P protein function. Further studies are necessary to reveal the relationship between the ability of P protein to interact with IKKe and pathogenesis of virus strain.
To reveal the functional mechanism of P protein in inhibition of IKKe, we investigated the domain of the P protein responsible for the function and found that the C-terminal region of the P protein is important for interacting with IKKe and inhibiting its activation (Fig. 7) . Thus, our results suggest that an IKKe-binding region exists in the C-terminal region of the P protein. Alignment analysis showed that residues 150 to 180 of the P protein from RABV strains are variable (Fig. S3a) . There are nine amino acid differences between the C-terminal region of the Ni and 1088 P proteins (Fig. S3b, c) . Of these amino acid residues, six residues (aa 165, 171, 177, 183, 193 and 281) are chemically similar between the Ni and 1088 P proteins, but three residues (aa 169, 173 and 174) are dissimilar. Notably, six of the nine amino acid differences were found between aa 165 and 177 (Fig. S3b) . A recent study showed that deletion of residues 176 to 186 of the RABV P protein strongly impaired the ability of the P protein to inhibit IRF-3 activation (Rieder et al., 2011) . Thus, we speculate that one or a combination of these six amino acid residues near aa 176 to 186 of the P protein is important to interact with IKKe and inhibit its activity. However, although aa 173 mutation affected the phenotype slightly, the function of 1088 P for inhibition of IKKe-mediated IRF-3 activity was not completely lost by the single mutations (Fig. S3d) . Further studies need to focus on fine mapping the interaction between RABV P and IKKe.
In this study, we showed that P proteins from lyssaviruses LBV, MOKV and DUVV also inhibited RIG-I-mediated IRF-3 activity at the same level as P proteins from fixed RABV strains, but less than that of street strains (Fig. 2) . Recently, Koraka et al. (2012) reported that DUVV shows similar peripheral pathogenicity in mice to that of the RABV fixed strain, but is less pathogenic than an RABV street strain. Moreover, LBV and MOKV are less pathogenic in mice after intramuscular infection (Badrane et al. 2001) .
Although the relationships between pathogenesis and P proteins from these lyssaviruses are unknown, we speculate that the ability of the P protein to inhibit IRF-3 activity and viral pathogenicity may be correlated.
Taken together, we showed novel evidence that the RABV P protein interacts with IKKe and inhibits the activation of IKKe-mediated IRF-3 activity. We believe that this is the first finding of a molecular mechanism underlying P protein antagonism of IKKe activity. Moreover, interestingly, the function of P protein varies between virus strains. Further studies are needed to elucidate the detailed molecular function of RABV P protein for inhibition of IFN induction signalling. We believe that the findings in this study will be useful for understanding the immune evasion strategy of RABV and for the development of antiviral drugs and attenuated live vaccines.
METHODS
Cells and viruses. Human embryonic kidney 293T cells were maintained in Dulbecco's minimum essential medium supplemented with 10% FCS, penicillin (100 U ml 21 ), streptomycin (100 mg ml
21
) and L-glutamine (2 mM). Human neuroblastoma SYM-I cells were maintained in Eagle's minimum essential medium supplemented with 10% FCS, penicillin (100 U ml
) and streptomycin (100 mg ml 21 ). The NDV B-1 vaccine strain was grown in 10 day-old embryonated chicken eggs and stored at 280 uC until further use.
Plasmids. Plasmids expressing the N-terminal Flag-tagged P protein from RABV-fixed viruses Ni strain (AB044824) and CVS-11 strain (GQ918139), RABV street viruses 1088 strain (AB645847) and HCM-9 strain (Yamagata et al., 2007) , Lyssaviruses LBV (AF049114), MOKV (KF155005) and DUVV (EU293119) were generated in a mammalian expression plasmid pCAGGS/MCS (Kobasa et al., 1997) . T. Masatani and others pRL-TK, which encoded Renilla luciferase under the control of the herpes simplex virus thymidine kinase promoter, was purchased from Promega. The following constructs were a kind gift from Dr Takashi Fujita (Kyoto University, Kyoto, Japan): p125-Luc (IFN-b promoter reporter plasmid), p55-C1B-Luc (IRF-3-dependent IFN-b promoter reporter plasmid) (Yoneyama et al., 1996) , pEF-Flag-RIG-IN (expression plasmid for constitutively active RIG-I mutant) (Yoneyama et al., 2005) , pEF-HA-IRF-3-5D (expression plasmid for constitutively active IRF-3 mutant) and pEF-BOS(+) (empty plasmid). The following constructs were a kind gift from Dr Shizuo Akira (Osaka University, Osaka, Japan): pEF-Flag-TBK1 and pEF-Flag-IKKe (expression plasmids for TBK1 and IKKe, respectively). Plasmids expressing the N-terminal myc-tagged TBK1 and IKKe were generated in pCAGGS/MCS. The resulting plasmids were named pCAG-myc-TBK1 and pCAG-myc-IKKe, respectively. An In-Fusion HD cloning kit (Clontech) was used to generate plasmids expressing the chimeric P protein comprising the N-terminus (aa 1-151) of Ni P and C-terminus (aa 152-297) of 1088 P and the counterpart comprising the N-terminus of 1088 P and C-terminus of Ni P (pCAG-Flag-Ni-10P and pCAG-Flag-10-NiP, respectively). A QuikChange Site-directed mutagenesis kit (Agilent Technology) was used to generate plasmids expressing the single point-mutated 1088 P proteins, pCAGFlag-1088P (L169S), -1088P (T173M) and -1088P (M174A), in which an amino acid at positions 169, 173 and 174 in 1088 P protein was replaced with that of the Ni P. Details pertaining to the construction of these plasmids and sequences of primers are available on request.
Reporter assay. Transfection of 293T cells was performed by using TransIT-293 reagent (Mirus Bio) according to the manufacturer's instructions. Transfection of SYM-I cells was performed by using Lipofectamine 2000 (Invitrogen) according to the manufacturer's instructions. Briefly, cells were seeded in a 24-well tissue culture plate at 3|10 5 cells per well. Twenty-four hours later, cells were co-transfected with 0.25 mg of each reporter plasmid (p125-Luc or p55-C1B-Luc), 0.025 mg of pRL-TK (to normalize transfection efficiency) along with 0.25 mg of each inducer plasmid (pEF-Flag-RIG-IN, pEF-HA-IRF-3-5D, pEF-Flag-TBK1 or pEF-Flag-IKKe) and 1 mg of each P protein-expression plasmid. The empty pCAGGS/MCS plasmid and pEF-BOS(+) plasmid were used as negative controls. Cells were incubated for 24 h. For NDV stimulation, cells were infected with NDV (m.o.i. of 1) at 24 h post-transfection and incubated for 12 h. Activities of firefly and Renilla luciferases were determined by using a Dual-Luciferase Reporter Assay System (Promega) according to the manufacturer's instructions. The data represent firefly luciferase activity normalized to Renilla luciferase activity. All assays were carried out in triplicate and the results expressed as means+SD.
Western blotting. Cells were lysed in radio-immunoprecipitation assay (RIPA) buffer (50 mM Tris/HCl [pH 7.5], 150 mM NaCl, 1 mM EDTA, 1% NP-40) supplemented with cOmplete mini ULTRA (Roche Diagnostics) and Phosphatase inhibitor cocktail (Nakarai tesque). Cell lysate samples were separated by 12% SDS-PAGE before transfer onto Immobilon-P transfer membranes (Millipore). Protein expression was determined by Western blotting using an anti-b-actin mouse monoclonal antibody (A5441; Sigma), anti-Flag mouse monoclonal antibody (M2; Sigma) (1:2000), anti-Flag rabbit polyclonal antibody (PM020; MBL) (1:2000), anti-myc rabbit polyclonal antibody (562; MBL) (1:2000), anti-phosphorylated IRF-3 rabbit monoclonal antibody (4D4G; Cell Signalling) (1:1000) or anti-IRF-3 rabbit polyclonal antibody (FL-425, Santa Cruz) (1:1000). For the secondary antibody, a HRP-conjugated anti-mouse IgG (Bethyl) (1:4000) or HRP-conjugated anti-rabbit IgG (GE Healthcare) (1:4000) were used. Protein bands were visualized by using ECL Prime Western blotting detection reagent (GE Healthcare) and images were taken using a Fusion Solo S (Vilber-Lourmat). Densitometry analysis was carried out by using ImageJ software.
Briefly, the intensity of images of scanned Western blots was determined, and the ratio of each band to its b-actin control was calculated.
Co-immunoprecipitation. cells were seeded in a 12-well tissue culture plate at 5|10 5 cells per well. Twenty-four hours later, cells were co-transfected with plasmids expressing various Flag-tagged P proteins (0.25 mg per well) and pCAG-myc-TBK1 or pCAG-mycIKKe (0.25 mg per well). Cells were lysed 24 h post-transfection with RIPA buffer supplemented with cOmplete mini ULTRA. Cell lysates were incubated for 2 h on a rotation wheel at 4 uC with SureBeads protein G magnetic beads (Bio-Rad) previously incubated with the appropriate antibody (anti-Flag mouse monoclonal antibody: M2, Sigma; or anti-myc mouse monoclonal antibody: 4E10, Santa Cruz) in order to precipitate the target protein. After the washing steps with Tris-buffered saline supplemented with 0.1% Tween-20, which were performed five times, magnetic beads were resuspended in SDS-PAGE sample buffer and heated to elute the bound proteins. Eluted proteins were then separated by SDS-PAGE and analysed by Western blotting.
Statistical analysis. A Tukey's multiple comparison test was used to determine statistical significance. A P-value of v0.05 was considered statistically significant.
